Vitrum cardio OMEGA-3 - instructions for use, dose, side effects, contraindications

Active substanceOmega-3 triglycerides [EPA / DHA = 1.5 / 1 - 50%]Omega-3 triglycerides [EPA / DHA = 1.5 / 1 - 50%]

Similar drugsTo uncover

Vitrum® cardio OMEGA-3

capsules inwards

Unipharm, Inc. USA

Eifitol

capsules inwards

Dosage form: & nbspcapsules

Composition:

one capsule contains:

Active active ingredients:

Omega-3-polyunsaturated fatty acids, ethyl esters, 1000 mg including:

Eicosapentaenoic acid (EPA) 300 mg

Docosahexaenoic acid (DHA) 200 mg

Alfa-tocopherol (Vitamin E) 2.00 mg

Capsule shell composition: gelatin - 261.7 mg, glycerol - 117.8 mg, water purified - 235.5 mg.

Description:

Transparent, from light yellow to dark yellow, oval shaped soft gelatin capsules. The contents of capsules are a transparent oily liquid from light yellow to dark yellow with a specific odor.

Pharmacotherapeutic group:Lipid-lowering drug

ATX: & nbsp

C.10.A.X.06 Omega-3 triglycerides, including other esters and acids

Pharmacodynamics:

The drug is a combination of polyunsaturated fatty acids (PUFA) family of omega-3 eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and vitamin E. The drug is used for violations of lipid metabolism, due to severe hypertriglyceridemia, has anti-inflammatory effect.Helps normalize the content of LDL and VLDL, change the fluid properties of cell membranes and increase the functional activity of membrane receptors, which contributes to improving the lipid-cell interaction of lipoproteins with enzymes, improving the metabolism of lipoproteins. Promotes the normalization of blood lipid metabolism. Antiaggregate effect of the drug is associated with the replacement of arachidonic acid in the phospholipid composition of the cell membrane or with inhibition of platelet aggregation as a result of the effect on lipid properties of receptors with thromboxane A2 / prostaglandin H2. Anti-inflammatory effect is due to a decrease in the production of prostaglandin E2 metabolites. achieved by the inclusion of essential fatty acids in the biosynthesis. Omega-3 polyunsaturated fatty acids inhibit inflammation, reduce the ability of arteries to vasoconstriction, reduce platelet aggregation.

This complex of essential polyunsaturated fatty acids is used to normalize lipid metabolism and reduce the risk of developing atherosclerosis.

Vitamin E has antioxidant activity,participates in tissue respiration and other important processes of tissue metabolism; protects cells and tissues from the damaging effect of excess amounts of free radicals and peroxide products.

Indications:

- prevention of dyslipidemia (violation of lipid metabolism);

- complex therapy of lipid metabolism disorders, including including a diet, statins.

Contraindications:Hypersensitivity to the drug components, exacerbation of chronic cholecystitis and pancreatitis, exacerbation of diseases of the hepatobiliary system, cholelithiasis; pathological conditions, including hemorrhagic syndrome. Children under 18 years.

Pregnancy and lactation:

During pregnancy and breastfeeding, it is recommended that you take the drug only as directed by your doctor.

Dosing and Administration:

It is recommended to take the adults inside by washing with water:

- with the preventive purpose - 1 capsule per day, 30 minutes after eating;

- with therapeutic - 1 capsule 2-3 times a day, 30 minutes after eating.

The course of treatment is not less than 3 months. Repeated courses on the recommendation of a doctor.

Side effects:

Allergic reactions.Disorders from the gastrointestinal tract: gastroesophageal reflux or belching with the smell or taste of fish, nausea, vomiting, diarrhea.

With prolonged use in large doses, exacerbation of chronic pancreatitis is possible.

Overdose:

Symptoms of an overdose: pain in the epigastric region, dyspeptic disorders (nausea, vomiting, diarrhea).

Treatment: symptomatic, cancellation of the drug.

Interaction:

Simultaneous reception with oral anticoagulants helps increase the risk of bleeding time. Simultaneous reception with warfarin does not lead to the development of hemorrhagic complications (however, with combined admission or after stopping the course of treatment with the drug, prothrombin time control is necessary).

It is not recommended simultaneous reception with fibrates. During the reception of the drug "VITRUM® CARDIO OMEGA-3", it is not recommended to take other preparations containing vitamin E.

Special instructions:

Do not exceed the recommended daily dose.

Effect on the ability to drive transp. cf. and fur:No data.

Form release / dosage:

Capsules.

Packaging:

For 30, 60, 100 or 120 capsules in a bottle of polyethylene with a screw cap made of the same material and a safety valve made of foil and a protective strip of polyethylene. The label is attached to the bottle, the bottle is tightened with a polyethylene film and, together with the instruction for use, is placed in a cardboard box.

Storage conditions:

In a dry place at a temperature of 10-30 ° C.

Keep out of the reach of children.

Shelf life:3 years. Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:LS-000548

Date of registration:06.05.2010

Expiration Date:Unlimited

The owner of the registration certificate:Unipharm, Inc.Unipharm, Inc. USA

Manufacturer: & nbsp

UNIPHARM ,, Inc. USA

Representation: & nbspUNIFARM, Inc. UNIFARM, Inc. USA

Information update date: & nbsp24.02.2017

Illustrated instructions

Instructions

Vitrum® cardio OMEGA-3 (Vitrum® cardio OMEGA-3)